Sprouts Farmers Market closes $600 million revolving credit facility
Investing.com - Tela Bio (NASDAQ: TELA) reported third quarter EPS of $-0.420, $0.02 worse than the analyst estimate of $-0.400. Revenue for the quarter came in at $19M versus the consensus estimate of $18.85M.
Guidance
Tela Bio sees FY 2024 revenue of $74.500M-$76.500M versus the analyst consensus of $74.400M.
Tela Bio's stock price closed at $2.99. It is down -26.350% in the last 3 months and down -48.450% in the last 12 months.
Tela Bio saw 3 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Tela Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Tela Bio's Financial Health score is "fair performance".
Check out Tela Bio's recent earnings performance, and Tela Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar